China SXT Pharmaceuticals, Inc.（SXTC）重大事項與業績發布
| 申報日 | 表別 | 事項 | 原文 |
|---|---|---|---|
| 2026-08-28 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-07-24 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-07-06 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-06-01 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-05-04 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-04-09 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2026-01-13 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-12-31 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-07-29 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-07-15 | 6-K | CURRENT REPORT | SEC |
| 2025-06-16 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-05-13 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-03-28 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-03-19 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-01-27 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2025-01-23 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2024-10-15 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2024-05-14 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
| 2024-04-05 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | SEC |
資料來自 SEC EDGAR 的 8-K／6-K 申報。8-K 是美國國內發行人的重大事項揭露（Item 2.02 為業績發布）；6-K 是外國發行人（含 ADR）的對應形式。本站僅整理連結，原文一律在 SEC 網站。